Dimethyl Sulfoxide

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Unlabeled Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Toxicological Effects
  • Genes that may be involved
  • Substrate of
  • Inhibits
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

North America

Canada: Dimethyl Sulfoxide, Domoso, Kemsol, Rimso; USA: Dimethyl Sulfoxide, Rimso.

Drug combinations

Dimethyl Sulfoxide and Dexamethasone

Dimethyl Sulfoxide, Dexpanthenol, and Heparin

Dimethyl Sulfoxide, Salicylic Acid, and Tretinoin

Chemistry

Dimethyl Sulfoxide: C~2~H~6~OS. Mw: 78.13. (1) Methane, sulfinylbis-; (2) Methyl sulfoxide. CAS-67-68-5 (1965).

Pharmacologic Category

Genitourinary Smooth Muscle Relaxants. Antioxidant. (ATC-Code: G04BX13; M02AX03).

Mechanism of action

Exact mechanism unknown. Induces and alters inflammatory tissue responses, modulates collagen disposition, influences nerve conduction and neurotransmission, and alters cell proliferation in fibroblasts and hepatocytes; thus exerting an anti-inflammatory, analgesic, and muscle-relaxant effect. It may also interact with free radicals forming formaldehyde, possibly contributing to fixative effect on biological tissues.

Therapeutic use

Symptomatic relief of interstitial cystitis.

Pregnancy and lactiation implications

Unknown risk. Teratogenic in animals. Use caution during lactation.

Unlabeled use

I.V. use to reduce intracranial pressure in trauma patients. Also being studied for its free radical scavenging properties, stress-induced gastric ulcers, and tissue protectant.

Contraindications

No contraindications listed within the manufacturer’s labeling.

Warnings and precautions

May cause hypersensitivity reactions (rare). Ophthalmic effects in animal studies (precaution in humans). Use with caution in urinary tract malignancy (may be harmful due to vasodilatory effects). For bladder instillation only (do not administer I.V./I.M.).

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart